Developing small molecule inhibitors of TLR8 for treatment of rheumatoid arthritis
Ended Project Grant Awarded Last action
- Award ID
- R44AI100376
- Recipient
-
Dynavax Technologies Corporation UEI JA7GSG397PL1
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $668,603
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Place of performance
- Berkeley, CA 94710, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$343,664 | |
| Amendment | $58,707 | |
| Amendment | $16,295 | |
| Amendment | $406,490 | |
| Original award | $530,775 |
Quick answers
Who received award R44AI100376?
R44AI100376 was awarded to Dynavax Technologies Corporation by National Institutes of Health (Department of Health and Human Services) on April 1, 2012.
How much is award R44AI100376 worth?
$668,603 has been obligated on R44AI100376.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award